Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

China SXT Pharmaceuticals (SXTC) Shares Outstanding (Diluted Average) (2018 - 2025)

China SXT Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 8 years, most recently at $116.0 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 3490.68% year-over-year to $116.0 million; the TTM value through Sep 2025 reached $116.0 million, up 3490.68%, while the annual FY2022 figure was $41591.0, 94.22% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $116.0 million at China SXT Pharmaceuticals, up from $3.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $777.5 million in Q3 2021 and troughed at $41591.0 in Q1 2022.
  • A 5-year average of $214.5 million and a median of $102.3 million in 2022 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 5302.78% in 2021 and later plummeted 99.36% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $777.5 million in 2021, then crashed by 86.84% to $102.3 million in 2022, then soared by 390.12% to $501.5 million in 2023, then plummeted by 99.36% to $3.2 million in 2024, then soared by 3490.68% to $116.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SXTC at $116.0 million in Q3 2025, $3.2 million in Q3 2024, and $501.5 million in Q3 2023.